BPC
ABBV icon

Bearing Point Capital’s AbbVie ABBV Stock Holding History

Bearing Point Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.19M Buy
14,662
+110
+0.8% +$24.4K 0.5% 62
2025
Q4 		$3.32M Buy
14,552
+306
+2% +$69.7K 0.52% 62
2025
Q3 		$3.3M Sell
14,246
-1,216
-8% -$248K 0.57% 58
2025
Q2 		$2.87M Buy
15,462
+352
+2% +$65.4K 0.53% 60
2025
Q1 		$3.17M Sell
15,110
-944
-6% -$184K 0.67% 55
2024
Q4 		$2.85M Buy
+16,054
New +$2.95M 0.59% 53

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bearing Point Capital's ABBV Position: Q1 2026 in Review

Bearing Point Capital increased its AbbVie (ABBV) stake by 0.76% in Q1 2026, buying an estimated $24.4K and bringing the position to 14,662 shares worth $3.19M. The position accounts for 0.5% of the portfolio, ranked #62.

Bearing Point Capital first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.32M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bearing Point Capital held 14,662 shares of AbbVie worth $3.19M as of Q1 2026.
  • Bearing Point Capital bought 110 AbbVie shares in Q1 2026, an estimated $24.4K.
  • AbbVie made up 0.5% of Bearing Point Capital's portfolio in Q1 2026, its #62 holding.
  • Bearing Point Capital first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Bearing Point Capital's AbbVie position peaked at $3.32M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bearing Point Capital's 13F filing for Q1 2026, filed 7 May 2026.